Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
Authors:
Top Cited Papers
- 1 November 2020
- journal article
- review article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 262, 113164
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Traditional Chinese Medicine Administration (2018YY001)
- Shaanxi Administration of Traditional Chinese Medicine (2018YY001)
This publication has 203 references indexed in Scilit:
- Activation of transient receptor potential vanilloid 1 decreases endothelial nitric oxide synthase phosphorylation at Thr497 by protein phosphatase 2B‐dependent dephosphorylation of protein kinase CActa Physiologica, 2013
- Anti-Proliferative Effects of Evodiamine on Human Breast Cancer CellsPLOS ONE, 2013
- Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric TumorsPLOS ONE, 2013
- Pharmacological Actions of Multi-Target-Directed EvodiamineMolecules, 2013
- Evodiamine induces apoptosis in pancreatic carcinoma PANC-1 cells via NF κB inhibitionBangladesh Journal of Pharmacology, 2012
- Design and Evaluation of a Novel Evodiamine-Phospholipid Complex for Improved Oral BioavailabilityAAPS PharmSciTech, 2012
- Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the badSeminars in Cancer Biology, 2011
- Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia rutaecarpaMolecules, 2009
- Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I ActivityMolecules, 2009
- Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytesLife Sciences, 2004